What is it about?

Polymorphisms of inducible nitric oxide synthase (NOS2) gene is related to fractional exhaled nitric oxide (FeNO) level in steroid-naive patients with asthma, but its association with treatment outcomes remains unclear. Thus, in this study, we aimed to clarify the association of NOS2 polymorphism with exacerbations in patients with asthma.

Featured Image

Why is it important?

We observed an association of NOS2 pentanucleotide repeat polymorphism with changing NOS2 mRNA expression levels, which were highest in subjects having ≤11 allele repetitions of CCTTT polymorphism, whereas there were no significant differences in FeNO levels and NOx concentrations between the genotype groups. Moreover, our results suggested that having allele ≤11 repeats contributes to increasing the risk of exacerbation in patients with moderate to severe asthma.

Read the Original

This page is a summary of: Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations, Journal of Allergy and Clinical Immunology, March 2018, Elsevier,
DOI: 10.1016/j.jaci.2018.02.023.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page